Cargando…
A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry
Jinshui-Huanxian granules (JHGs), a Chinese herbal compound prescription, have shown a therapeutic effect in reducing lung tissue damage, improving the degree of pulmonary fibrosis, replenishing lungs and kidneys, relieving cough and asthma, reducing phlegm, and activating blood circulation. However...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534582/ https://www.ncbi.nlm.nih.gov/pubmed/37764268 http://dx.doi.org/10.3390/molecules28186492 |
_version_ | 1785112428468502528 |
---|---|
author | Zhang, Weiwei Wan, Yan Sun, Shuding Xie, Yang Zhao, Di Li, Bing Li, Jiansheng Tian, Yange Feng, Suxiang |
author_facet | Zhang, Weiwei Wan, Yan Sun, Shuding Xie, Yang Zhao, Di Li, Bing Li, Jiansheng Tian, Yange Feng, Suxiang |
author_sort | Zhang, Weiwei |
collection | PubMed |
description | Jinshui-Huanxian granules (JHGs), a Chinese herbal compound prescription, have shown a therapeutic effect in reducing lung tissue damage, improving the degree of pulmonary fibrosis, replenishing lungs and kidneys, relieving cough and asthma, reducing phlegm, and activating blood circulation. However, these active compounds’ pharmacokinetics and metabolic processes were unclear. This study aimed to compare the pharmacokinetics, reveal the metabolic dynamic changes, and obtain the basic pharmacokinetic parameters of 16 main bioactive compounds after intragastric administration of JHGs in control and pulmonary fibrosis (PF) model rats by using Orbitrap Fusion MS. After administration of JHGs, the rat plasma was collected at different times. Pretreating the plasma sample with methanol and internal standard (IS) solution carbamazepine (CBZ), and it was then applied to a C(18) column by setting gradient elution with a mobile phase consisting of methanol 0.1% formic acid aqueous solution. Detection was performed on an electrospray ionization source (ESI), and the scanning mode was SIM. Pharmacokinetic parameters were analyzed according to the different analytes’ concentrations in plasma. The matrix effect was within the range of 79.01–110.90%, the extraction recovery rate was 80.37–102.72%, the intra-day and inter-day precision relative standard deviation (RSD) was less than 7.76%, and the stability was good, which met the requirements of biological sample testing. The method was validated (r ≥ 0.9955) and applied to compare the pharmacokinetic profiles of the control group and PF model group after intragastric administration of the JHGs. The 16 analytes exhibited different pharmacokinetic behaviors in vivo. In the pathological state of the PF model, most of the components were more favorable for metabolism and absorption, and it was more meaningful to study the pharmacokinetics. Above all, this study provided an essential reference for exploring the mechanism of action of JHGs and guided clinical medication as well. |
format | Online Article Text |
id | pubmed-10534582 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105345822023-09-29 A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry Zhang, Weiwei Wan, Yan Sun, Shuding Xie, Yang Zhao, Di Li, Bing Li, Jiansheng Tian, Yange Feng, Suxiang Molecules Article Jinshui-Huanxian granules (JHGs), a Chinese herbal compound prescription, have shown a therapeutic effect in reducing lung tissue damage, improving the degree of pulmonary fibrosis, replenishing lungs and kidneys, relieving cough and asthma, reducing phlegm, and activating blood circulation. However, these active compounds’ pharmacokinetics and metabolic processes were unclear. This study aimed to compare the pharmacokinetics, reveal the metabolic dynamic changes, and obtain the basic pharmacokinetic parameters of 16 main bioactive compounds after intragastric administration of JHGs in control and pulmonary fibrosis (PF) model rats by using Orbitrap Fusion MS. After administration of JHGs, the rat plasma was collected at different times. Pretreating the plasma sample with methanol and internal standard (IS) solution carbamazepine (CBZ), and it was then applied to a C(18) column by setting gradient elution with a mobile phase consisting of methanol 0.1% formic acid aqueous solution. Detection was performed on an electrospray ionization source (ESI), and the scanning mode was SIM. Pharmacokinetic parameters were analyzed according to the different analytes’ concentrations in plasma. The matrix effect was within the range of 79.01–110.90%, the extraction recovery rate was 80.37–102.72%, the intra-day and inter-day precision relative standard deviation (RSD) was less than 7.76%, and the stability was good, which met the requirements of biological sample testing. The method was validated (r ≥ 0.9955) and applied to compare the pharmacokinetic profiles of the control group and PF model group after intragastric administration of the JHGs. The 16 analytes exhibited different pharmacokinetic behaviors in vivo. In the pathological state of the PF model, most of the components were more favorable for metabolism and absorption, and it was more meaningful to study the pharmacokinetics. Above all, this study provided an essential reference for exploring the mechanism of action of JHGs and guided clinical medication as well. MDPI 2023-09-07 /pmc/articles/PMC10534582/ /pubmed/37764268 http://dx.doi.org/10.3390/molecules28186492 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhang, Weiwei Wan, Yan Sun, Shuding Xie, Yang Zhao, Di Li, Bing Li, Jiansheng Tian, Yange Feng, Suxiang A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry |
title | A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry |
title_full | A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry |
title_fullStr | A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry |
title_full_unstemmed | A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry |
title_short | A Pharmacokinetic Study of Sixteen Major Bioactive Components of Jinshui-Huanxian Granules in Pulmonary Fibrosis Model and Control Rats Using Orbitrap Fusion Mass Spectrometry |
title_sort | pharmacokinetic study of sixteen major bioactive components of jinshui-huanxian granules in pulmonary fibrosis model and control rats using orbitrap fusion mass spectrometry |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534582/ https://www.ncbi.nlm.nih.gov/pubmed/37764268 http://dx.doi.org/10.3390/molecules28186492 |
work_keys_str_mv | AT zhangweiwei apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT wanyan apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT sunshuding apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT xieyang apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT zhaodi apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT libing apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT lijiansheng apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT tianyange apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT fengsuxiang apharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT zhangweiwei pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT wanyan pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT sunshuding pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT xieyang pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT zhaodi pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT libing pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT lijiansheng pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT tianyange pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry AT fengsuxiang pharmacokineticstudyofsixteenmajorbioactivecomponentsofjinshuihuanxiangranulesinpulmonaryfibrosismodelandcontrolratsusingorbitrapfusionmassspectrometry |